**Executive Summary**
Union Minister Shri J. P. Nadda visited NIPER Mohali on May 1, 2026, to review biopharmaceutical research and inaugurate the NIPER Medicinal Succulents Garden. The visit emphasized the government's commitment to strengthening research infrastructure, accelerating technology transfer, and transitioning from academic patents to real-world commercialization. Key highlights include the alignment with the Biopharma SHAKTI mission and the introduction of new specialized Master’s programmes to build industry-ready talent.
**Key Points / Main Content**
**Institutional Reviews and Inaugurations**
* **Inauguration:** The Minister officially opened the NIPER Medicinal Succulents Garden.
* **Strategic Review:** Review of the institute’s strategic vision, innovation ecosystem, and roadmaps for industry linkages.
* **Technology Showcase:** Review of posters and prototypes demonstrating translational research, industry collaborations, patents, and clinical trial initiatives.
**Government Strategic Priorities**
* **Sector Focus:** Commitment to positioning India at the forefront of Biopharmaceutical advancements, specifically in APIs, key starting materials, synthesis intermediates, and biologics.
* **Infrastructure and Support:** Assured continued policy support and funding to strengthen research infrastructure and accelerate innovation.
* **Mission Alignment:** Active participation in the Government’s Biopharma SHAKTI mission involving cell and gene therapies, biosimilars, and AI-driven pharmacoinformatics.
**Proposed Reforms and Academic Changes**
* **Performance Rewards:** Proposed reforms to the faculty reward system to incentivize the securing of external funding and industry-sponsored research.
* **Commercialization Shift:** Emphasis on moving beyond “paper patents” toward real-world translation and commercialization to enhance national impact.
* **New Curriculum:** Introduction of new Master’s programmes in Biopharmaceuticals and Regulatory Affairs to develop future-ready talent.
**Impact Analysis**
**NIPER Mohali Faculty and Administration**
**Impact**
Faculty are subject to proposed shifts in performance evaluation, focusing on their ability to secure external funding and industry-sponsored projects.
**Action Required**
Administrators and faculty must reform reward systems and prioritize the transition of research into commercialized products and technology transfers.
**Students and Pharmaceutical Professionals**
**Impact**
Students gain access to updated, industry-aligned curricula and new specialized degree paths.
**Action Required**
Prospective students should engage with the new Master’s programmes in Biopharmaceuticals and Regulatory Affairs to align with the demand for industry-ready talent.
**Pharmaceutical Industry**
**Impact**
The industry stands to benefit from enhanced collaboration opportunities, a stronger pipeline of translational research, and a more robust biopharmaceutical ecosystem.
**Action Required**
Industry stakeholders are encouraged to increase collaboration with the institute for technology transfer and sponsored research initiatives.
Key Entities Referenced
National Institute of Pharmaceutical Education and Research (NIPER), Mohali: The premier pharmaceutical research and education institute focused on biopharmaceutical innovation, translational research, and industry collaboration.
Biopharma SHAKTI mission: A government initiative aimed at advancing cutting-edge work in cell and gene therapies, biosimilars, medical devices, and AI-driven pharmacoinformatics.
Department of Pharmaceuticals: The primary department under the Ministry of Chemicals and Fertilizers providing policy support, funding, and reforms for pharmaceutical research and technology transfer.
Shri J. P. Nadda: Union Minister for Chemicals & Fertilizers and Health & Family Welfare who reviewed the institute's strategic vision and inaugurated new research facilities.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
Union Minister Shri J. P. Nadda Visits NIPER
Mohali, Reviews Biopharma Research and
Innovation
Inaugurates NIPER Medicinal Succulents Garden;
Emphasises on Translational Research and Industry
Collaboration
Posted On: 01 MAY 2026 6:10PM by PIB Delhi
Union Minister for Chemicals & Fertilizers and Health & Family Welfare Shri. Jagat Prakash Nadda
visited the National Institute of Pharmaceutical Education and Research (NIPER), Mohali today. During
the visit, Minister inaugurated the NIPER Medicinal Succulents Garden.
Shri Nadda reviewed the institute’s strategic vision, research priorities, and innovation ecosystem. A
comprehensive presentation by Prof. Dulal Panda Director, NIPER Mohali highlighted key performance
indicators and the roadmap for strengthening research and industry linkages. The institute showcased its
Centres of Excellence, including advanced work in biopharmaceuticals and emerging therapeutic domains,
along with ongoing initiatives in technology transfer and commercialization.Addressing the gathering, Shri Nadda emphasized the Government of India’s commitment to positioning
the country at the forefront of biopharmaceutical advancements, particularly in APIs, key starting
materials, synthesis intermediates, and biologics. He underscored the importance of strengthening
research infrastructure and assured continued policy support and funding to accelerate innovation and
execution in the sector. He also appreciated the institute’s role in nurturing skilled, industry-ready
professionals contributing to national growth.
Shri Manoj Joshi, Secretary, Department of Pharmaceuticals interacted with faculty and students, inviting
suggestions on enhancing industry collaboration, technology transfer, and translational research outcomes.
He emphasized the need for reforms in the reward system to drive performance, suggesting incentives
for faculty securing external funding and increasing industry-sponsored research. He also stressed the
importance of transitioning from “paper patents” to real-world translation and commercialization to
enhance national impact.
Highlighting the institute’s contributions, Prof. Dulal Panda reaffirmed its focus on research excellence
and its growing network of distinguished alumni. He outlined the institute’s active role in advancing the
Government’s Biopharma SHAKTI mission through cutting-edge work in cell and gene therapies,
biosimilars, medical devices, AI-driven pharmacoinformatics, and advanced drug delivery systems. The
introduction of new Master’s programmes in Biopharmaceuticals and Regulatory Affairs was also noted as
a step towards building future-ready talent.
The visit was followed by a Technology Showcase in the Convention Centre foyer, where the Union
Minister reviewed posters and prototypes demonstrating translational research outcomes. The showcase
featured industry collaborations, patents, and clinical trial initiatives undertaken by NIPER.
The visit underscores the Government of India’s sustained focus on strengthening pharmaceutical
education, promoting innovation, and advancing research and development to build a robust and self-
reliant biopharmaceutical ecosystem.
*****
PC/PM
(Release ID: 2257336) Visitor Counter : 246
Read this release in: Urdu , ही